NFKB1 and neoplasm: However, compared to the control group, xenograft tumor weight was not significantly altered in the rLV-GLP2 plus pcDNA3-NF-κB group (0.79 ± 0.165 g versus 0.833 ± 0.100 g; p > 0.05).